Last weekend I had a retreat with my team and patients who participate in clinical trials. It was a wonderful discussion circle where we aimed to seek assurance on the value of our work. Once again it was amazing to see the deep engagement the patients have in clinical trials - not only for themselves in the hope of receiving a better cure, but especially to help the next generation of patients get better treatments. And, how much patients want to be involved in the assessment of a trial.
How do we create and strengthen the collaboration between sponsors, investigators and patients in clinical trials? How do we achieve a closer patient centered partnership in clinical studies? What are the new ways of collaborating for improved clinical trial outcomes and better drug development?
These are the main topics that will be discussed at the Clinical Trail Collaboration conference on 3rd and 4th April in the Renaissance Boston Waterfront Hotel, Boston, MA.
I had the pleasure of speaking at the 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event last week in London. While not all innovation is disruptive, we can and should continue to drive down the cost of drug development and provide better access to clinical trials through technology, while greatly enhancing the patient experience. That indeed was the goal of this conference, providing case studies and examples of how to dramatically improve the patient experience in the clinical trial process.
For the past 2 days Be the Partner participated in the most patient centric forum in Europe: Patients as Partners Europe in London on Feb 6-7. This conference seeks to implement and advance patient involvement across the entire clinical development continuum. Speakers from industry, patients advocacy groups, investigators and patients themselves discussed the importance of understanding the patients needs and the collaboration between patients and industry.